Centrient Pharmaceuticals Initiates a Second Patent Litigation in India Against Dalas Biotech Limited

ROTTERDAM, The Netherlands, Oct. 18 (Korea Bizwire) — Centrient Pharmaceuticals announced that on October 14th 2019, its wholly owned subsidiary, Centrient Pharmaceuticals India Private Limited, filed a second lawsuit against Dalas Biotech Limited in the High Court of Delhi in New Delhi, India for patent infringement of Indian Patent Number 318914. This patent, which is owned [...]

Centrient Pharmaceuticals Initiates Patent Litigation in India Against Dalas Biotech Limited

ROTTERDAM, Holland, May 1 (Korea Bizwire) — Centrient Pharmaceuticals announced that on April 25, 2019, its wholly owned subsidiary, Centrient Pharmaceuticals India Private Limited, filed a lawsuit against Dalas Biotech Limited in the High Court of Delhi in New Delhi, India for patent infringement of Indian Patent Number 247301. This patent, which is owned by [...]